Product
Lyso-Thermosensitive Liposomal Doxorubicin
1 clinical trial
1 indication
Indication
Colorectal Cancer with Liver MetastasisClinical trial
Phase II Open Label Trial of Thermal Ablation and Lyso-Thermosensitive Liposomal Doxorubicin (Thermodox) for Metastatic Colorectal Cancer (mCRC) Liver LesionsStatus: Terminated, Estimated PCD: 2013-05-01